Subscribe To
Precipio’s omnia™ methodology enables diagnosis of mds with peripheral blood instead of bone marrow biopsy
Use of HemeScreen® technology enables diagnosis without the need for painful, invasive sampling NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) — ...
June 14, 2023, 1:49 pm
Correction — precipio continues to sign up and onboard hemescreen™ customers
Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated growth NEW HAVEN, Conn., Mar...
March 7, 2023, 5:49 pm
Precipio continues to sign up and onboard hemescreen™ customers
Conversion from sales funnels developed with distribution partners alongside direct sales points to continued accelerated growth NEW HAVEN, Conn., Mar...
March 7, 2023, 5:00 pm